Skip to main content

Ondansetron Hydrochloride Injection

Last Updated: January 10, 2023
Status: Current

Products Affected - Description
    • Ondansetron injection, Fosun Pharma, 2 mg/mL, 2 mL vial, 25 count, NDC 72266-0123-01
    • Ondansetron injection, Fresenius Kabi, 2 mg/mL, 2 mL vial, 25 count, NDC 63323-0373-02
    • Ondansetron injection, Hikma, 2 mg/mL, 2 mL vial, 25 count, NDC 00641-6078-25
    • Ondansetron injection, Hikma, 2 mg/mL, 20 mL vial, 1 count, NDC 00641-6079-01
    • Ondansetron injection, Pfizer, 2 mg/mL, 2 mL vial, 25 count, NDC 00409-4755-03
    • Ondansetron injection, Pfizer, 2 mg/mL, 20 mL vial, 1 count, NDC 00409-4759-01
    • Ondansetron injection, Sagent, 2 mg/mL, 2 mL vial, 25 count, NDC 25021-0777-02
Reason for the Shortage
    • Apotex has ondansetron injection available.
    • Athenex has ondansetron injection available.
    • Avet did not provide a reason for the shortage.
    • AuroMedics is no longer marketing ondansetron injection.
    • Fosun has ondansetron injection available.
    • Fresenius Kabi did not provide a reason for the shortage.
    • Hikma has ondansetron injection available.
    • Mylan Institutional discontinued ondansetron 2 mL vials in December 2021 and the 20 mL vials were discontinued in June 2022.
    • Pfizer has ondansetron injection on back order due to manufacturing delay.
    • Sagent discontinued ondansetron 20 mL vials in early-2021.
    • Novartis discontinued Zofran 20 mL vials in May 2018.
Available Products
    • Ondansetron injection, Apotex, 2 mg/mL, 2 mL vial, 25 count, NDC 60505-6130-05
    • Ondansetron injection, Athenex, 2 mg/mL, 2 mL vial, 25 count, NDC 70860-0776-02
    • Ondansetron injection, Athenex, 2 mg/mL, 20 mL vial, 10 count, NDC 70860-0777-21
    • Ondansetron injection, Avet Pharmaceuticals, 2 mg/mL, 2 mL vial, 25 count, NDC 23155-0547-42
    • Ondansetron injection, Avet Pharmaceuticals, 2 mg/mL, 20 mL vial, 1 count, NDC 23155-0549-31
    • Ondansetron injection, Fosun Pharma, 2 mg/mL, 20 mL vial, 1 count, NDC 72266-0124-01
    • Ondansetron injection, Fresenius Kabi, 2 mg/mL, 2 mL prefilled syringe, 24 count, NDC 76045-0103-20
    • Ondansetron injection, Fresenius Kabi, 2 mg/mL, 20 mL vial, 1 count, NDC 63323-0374-20

Estimated Resupply Dates

    • Fosun Pharma has ondansetron 2 mg/mL 2 mL vials on back order and the company cannot estimate a release date.
    • Fresenius Kabi has ondansetron 2 mg/mL 2 mL vials on back order and the company estimates a release date of mid-February 2023.
    • Hikma has ondansetron 2 mg/mL 2 mL and 20 mL vials on back order and the company estimates a release date of late-January to early-February 2023 for the 2 mL vials and mid-January 2023 for the 20 mL vials.
    • Pfizer has ondansetron 2 mg/mL 20 mL vials on back order and the company estimates a release date of November 2023. The 2 mL vials are available in limited supply.

Updated

Updated January 10, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 8, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.